The latest price target for Nutex Health (NASDAQ:NUTX) was reported by Maxim Group on November 12, 2024. The analyst firm set a price target for $50.00 expecting NUTX to rise to within 12 months (a possible 50.60% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Nutex Health (NASDAQ:NUTX) was provided by Maxim Group, and Nutex Health maintained their buy rating.

There is no last upgrade for Nutex Health

There is no last downgrade for Nutex Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutex Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutex Health was filed on November 12, 2024 so you should expect the next rating to be made available sometime around November 12, 2025.

While ratings are subjective and will change, the latest Nutex Health (NUTX) rating was a maintained with a price target of $45.00 to $50.00. The current price Nutex Health (NUTX) is trading at is $33.20, which is out of the analyst’s predicted range.